Top Markets
Coin of the day
BIOLASE, Inc. BIOLASE, Inc.

BIOLASE, Inc.

BIOL
Clasificación en acciones #42643
BIOLASE, Inc., along with its various divisions, operates as a global... BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.
Precio por acción
$0.00695
Última sincronización: 2024-10-29
Capitalización bursátil
$536.40
Cambio (1 día)
-0.71%
Cambio (1 año)
0.00%
País
US
Comercio BIOLASE, Inc. (BIOL)

Categoría

Ratio P/E de BIOLASE, Inc. (BIOL)
Ratio P/E al August 2026 TTM: 0.00
Según los últimos informes financieros y el precio de las acciones de BIOLASE, Inc., el P/E actual (TTM) de la empresa es 0.00. Al final de 2022, la empresa tenía un P/E de -0.16.
Historial del ratio P/E de BIOLASE, Inc. desde 2000 hasta 2026
Relación P/E al final de cada año
Año Ratio P/E Cambiar
2026 (TTM) 0.00 -98.29%
2023 -0.07 -55.88%
2022 -0.16 -95.59%
2021 -3.57 133.74%
2020 -1.53 113.47%
2019 -0.71 -24.55%
2018 -0.95 -49.66%
2017 -1.88 -65.94%
2016 -5.53 129.22%
2015 -2.41 -61.44%
2014 -6.25 -26.96%
2013 -8.56 -57.80%
2012 -20.28 13.38%
2011 -17.89 365.23%
2010 -3.85 -77.06%
2009 -16.76 297.64%
2008 -4.22 -48.97%
2007 -8.26 -82.35%
2006 -46.80 316.41%
2005 -11.24 -3.09%
2004 -11.60 -159.36%
2003 19.54 -56.04%
2002 44.44 -115.29%
2001 -290.61 3,034.63%
2000 -9.27 0.00%
Relación P/E para empresas similares o competidores
Empresa P/E Ratio Diferencia del P/E Ratio País
33.99 -2,832,358.33%
US
33.47 -2,789,583.33%
US
21.39 -1,782,416.67%
IE
18.84 -1,570,325.00%
US
49.47 -4,122,225.00%
US
¿Cómo leer un P/E ratio?

El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.

Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.

Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.